Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03995004Phase 1Suspended
Phase 1, randomised, double-blind trial of melatonin in postoperative pain (3 arms), sponsored by The University of Hong Kong. Primary endpoints: Subjective pain perception at 14 days and Total analgesic consumption at 14 days. Started Oct 2022; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03995004.